From Nasdaq: 2025-06-10 14:26:00

Ernexa Therapeutics (ERNA) has announced a 1-for-15 reverse stock split of its common shares, effective June 12, 2025, to meet Nasdaq’s $1.00 minimum bid requirement. Post-split, every 15 existing shares will convert into one new share, reducing outstanding shares from 110.4 million to 7.36 million. Shareholders will receive instructions from Computershare for the share exchange process. The reverse split was approved at a ratio of 1-for-15 at a shareholder meeting on June 2, 2025. ERNA is currently trading at $0.1649 on the NasdaqCM, down 12.7513%.



Read more at Nasdaq: Ernexa Announces 1-for-15 Reverse Stock Split Effective June 12 To Regain Nasdaq Compliance